NCT07303387
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07303387
Title Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. (EZHiSWITCH)
Acronym EZHiSWITCH
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Gustave Roussy RECRUITING Villejuif Val de Marne 94805 France Details
Institut Bergonié NOT_YET_RECRUITING Bordeaux 33076 France Details
Centre Léon Berard NOT_YET_RECRUITING Lyon 69373 France Details
Institut Curie NOT_YET_RECRUITING Paris 75005 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field